Utah Medical Products Inc

UTMDCIK 0000706698 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0063Δ-0.000194% similar+247/-227 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 4, 2026no items parsed Apr 23, 20262.02 · Results9.01 · Financial Statements and Exhibits99.1 Jan 29, 2026no items parsed Nov 4, 2025no items parsed Oct 23, 2025no items parsed

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.01pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Utah Medical Products Inc

Name	Roles	Filings
Koopman Brian	Officer	7
Richins Paul O	Director	5
Payne Barbara A	Director	3

Showing 1-3 of 3

Per pagePage 1 of 1

All filings

15 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jul 22, 2024	Koopman Brian Principal Financial Officer	GGift	50	$71.61	$3,581

Filed		Top transaction	Shares	Price	Value